{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:00:54Z","timestamp":1793916054141,"version":"4.8.0"},"reference-count":408,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100006292","name":"IDSA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Advances in antiretroviral therapy (ART) have made it possible for persons with human immunodeficiency virus (HIV) to have a lifespan that approaches that of people without HIV without progressing to AIDS or transmitting HIV to sexual partners or infants. There is, therefore, increasing emphasis on maintaining health throughout the lifespan. To receive optimal medical care and achieve desired outcomes, persons with HIV must be consistently engaged in care and able to access uninterrupted treatment, including ART. Comprehensive, evidence-based HIV primary care guidance is, therefore, more important than ever. Creating a patient-centered, stigma-free care environment is essential for care engagement. Barriers to care must be decreased at the societal, health system, clinic, and individual levels. As the population ages and noncommunicable diseases arise, providing comprehensive healthcare for persons with HIV becomes increasingly complex, including management of multiple comorbidities and the associated challenges of polypharmacy while also attending to HIV-specific health concerns. Clinicians must address issues specific to preventive health, including cancer screening, providing recommended vaccinations, and promoting sexual health, including sexually transmitted infection diagnosis, treatment, and prevention. Clinicians also must address issues for specific populations, including persons of childbearing potential during preconception and pregnancy, children, adolescents, and transgender and gender-diverse individuals. This guidance from an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America updates the previous 2020 HIV Primary Care Guidance.<\/jats:p>","DOI":"10.1093\/cid\/ciae479","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T15:22:09Z","timestamp":1727104929000},"source":"Crossref","is-referenced-by-count":151,"title":["Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America"],"prefix":"10.1093","author":[{"given":"Michael","family":"Horberg","sequence":"first","affiliation":[{"name":"Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic Permanente Medical Group , Washington, DC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0341-2400","authenticated-orcid":false,"given":"Melanie","family":"Thompson","sequence":"additional","affiliation":[{"name":"Thacker & Thompson, MD , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Agwu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Colasanti","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Emory University , Atlanta, Georgia ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Haddad","sequence":"additional","affiliation":[{"name":"Center for Key Populatons at Community Health Center, Inc. , Middletown, Connecticut ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine at UT Southwestern Medical Center and Peter O\u2019Donnell School of Public Health , Dallas, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"McComsey","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Medicine, Case Western Reserve University and University Hospitals of Cleveland , Cleveland, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Radix","sequence":"additional","affiliation":[{"name":"Department of Medicine, Callen-Lorde Community Health Center\u2013New York , New York City, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natella","family":"Rakhmanina","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, George Washington University School of Medicine and Health Sciences , Washington, DC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R","family":"Short","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Singh","sequence":"additional","affiliation":[{"name":"UCI Health, University of California\u2013Irvine , Irvine, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel","family":"Tookes","sequence":"additional","affiliation":[{"name":"Miller School of Medicine, University of Miami , Miami, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2025030419571680800_ciae479-B1","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B2","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B3","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B4","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B5","volume-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy","author":"World Health Organization","year":"2017"},{"key":"2025030419571680800_ciae479-B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society\u2013USA Panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B7","volume-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2023"},{"key":"2025030419571680800_ciae479-B8","volume-title":"Key ending the HIV epidemic strategies","author":"Office of Infectious Disease and HIV\/AIDS Policy, Department of Health and Human Services","year":"2022"},{"key":"2025030419571680800_ciae479-B9","volume-title":"National HIV\/AIDS strategy for the United States 2022\u20132025","author":"The White House","year":"2021"},{"key":"2025030419571680800_ciae479-B10","doi-asserted-by":"crossref","first-page":"ofy104","DOI":"10.1093\/ofid\/ofy104","article-title":"Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States","volume":"5","author":"Colasanti","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0000000000001938","article-title":"Retention in care trajectories of HIV-positive individuals participating in a universal test-and-treat program in rural South Africa (ANRS 12249 TasP trial)","volume":"80","author":"Gosset","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciad317","article-title":"Treatment outcomes after offering same-day initiation of human immunodeficiency virus treatment","volume":"77","author":"Labhardt","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0140-6736(23)00877-2","article-title":"The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review","volume":"402","author":"Broyles","year":"2023","journal-title":"Lancet"},{"key":"2025030419571680800_ciae479-B14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/QAI.0000000000001543","article-title":"Association between internalized HIV-related stigma and HIV care visit adherence","volume":"76","author":"Rice","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B15","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1016\/S2352-3018(23)00237-0","article-title":"Putting people first in communication about HIV","volume":"10","author":"The Lancet HIV","year":"2023","journal-title":"Lancet HIV"},{"key":"2025030419571680800_ciae479-B16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2652-12-15","article-title":"Combating HIV stigma in health care settings: what works?","volume":"12","author":"Nyblade","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"2025030419571680800_ciae479-B17","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2020"},{"key":"2025030419571680800_ciae479-B18","volume-title":"New York State Department of Health AIDS Institute Clinical Guidelines. Perioperative care in adults with HIV","author":"Yan","year":"2021"},{"key":"2025030419571680800_ciae479-B19","first-page":"1245","article-title":"Notes from the field: occupationally acquired HIV infection among health care workers\u2014United States, 1985\u20132013","volume":"63","author":"Joyce","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.athoracsur.2020.06.120","article-title":"Heart transplantation survival outcomes of HIV positive and negative recipients","volume":"111","author":"Doberne","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2025030419571680800_ciae479-B21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"2025030419571680800_ciae479-B22","first-page":"100553","article-title":"Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium","volume":"24","author":"Durand","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"2025030419571680800_ciae479-B23","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in HIV-infected recipients","volume":"363","author":"Stock","year":"2010","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B24","author":"Organ Procurement & Transplantation Network","year":"2015"},{"key":"2025030419571680800_ciae479-B25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.283.2.229","article-title":"Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens","volume":"283","author":"Havlir","year":"2000","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0000000000002142","article-title":"Antiretroviral adherence level necessary for HIV viral suppression using real-world data","volume":"82","author":"Byrd","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B28","doi-asserted-by":"crossref","first-page":"ofab032","DOI":"10.1093\/ofid\/ofab032","article-title":"Association of incomplete adherence to antiretroviral therapy with cardiovascular events and mortality in virologically suppressed persons with HIV: the Swiss HIV Cohort Study","volume":"8","author":"Castillo-Mancilla","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.15585\/mmwr.mm6849a1","article-title":"Nonadherence to any prescribed medication due to costs among adults with HIV infection\u2014United States, 2016\u20132017","volume":"68","author":"Beer","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 2","key":"2025030419571680800_ciae479-B30","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/QAI.0000000000001730","article-title":"Multimonth prescription of antiretroviral therapy among children and adolescents: experiences from the Baylor International Pediatric AIDS Initiative in 6 African countries","volume":"78","author":"Kim","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B31","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s10461-016-1340-y","article-title":"Retaining HIV patients in care: the role of initial patient care experiences","volume":"20","author":"Dang","year":"2016","journal-title":"AIDS Behav"},{"key":"2025030419571680800_ciae479-B32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12909-017-0868-5","article-title":"Building trust and rapport early in the new doctor-patient relationship: a longitudinal qualitative study","volume":"17","author":"Dang","year":"2017","journal-title":"BMC Med Educ"},{"key":"2025030419571680800_ciae479-B33","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/JNC.0000000000000076","article-title":"A systematic mixed studies review of the intersections of social-ecological factors and HIV stigma in people living with HIV in the U.S. South","volume":"30","author":"Ingram","year":"2019","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2025030419571680800_ciae479-B34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1468-1293.2012.01034.x","article-title":"Financial stress is associated with reduced treatment adherence in HIV-infected adults in a resource-rich setting","volume":"14","author":"McAllister","year":"2013","journal-title":"HIV Med"},{"key":"2025030419571680800_ciae479-B35","doi-asserted-by":"crossref","first-page":"ofz183","DOI":"10.1093\/ofid\/ofz183","article-title":"Improved perinatal and postpartum human immunodeficiency virus outcomes after use of a perinatal care coordination team","volume":"6","author":"Hackett","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-131-2-199907200-00002","article-title":"Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions","volume":"131","author":"Lucas","year":"1999","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/516778","article-title":"Retention in care: a challenge to survival with HIV infection","volume":"44","author":"Giordano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B38","volume-title":"Linkage to, retention in, and re-engagement in HIV care (LRC)","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2025030419571680800_ciae479-B39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.aids.0000161772.51900.eb","article-title":"Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care","volume":"19","author":"Gardner","year":"2005","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/QAI.0000000000002549","article-title":"Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV","volume":"86","author":"Ehrenkranz","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/cid\/ciu357","article-title":"Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics","volume":"59","author":"Gardner","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jamainternmed.2017.2158","article-title":"Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065)","volume":"177","author":"El-Sadr","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2025030419571680800_ciae479-B43","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/QAD.0000000000001406","article-title":"Cash vs. food assistance to improve adherence to antiretroviral therapy among HIV-infected adults in Tanzania","volume":"31","author":"McCoy","year":"2017","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/apc.2017.0303","article-title":"PositiveLinks: a mobile health intervention for retention in HIV care and clinical outcomes with 12-month follow-up","volume":"32","author":"Dillingham","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"2025030419571680800_ciae479-B45","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s10461-017-1954-8","article-title":"Project nGage: results of a randomized controlled trial of a dyadic network support intervention to retain young black men who have sex with men in HIV care","volume":"21","author":"Bouris","year":"2017","journal-title":"AIDS Behav"},{"key":"2025030419571680800_ciae479-B46","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200076","article-title":"Adaptive strategies for retention in care among persons living with HIV","volume":"2","author":"Geng","year":"2023","journal-title":"NEJM Evid"},{"key":"2025030419571680800_ciae479-B47","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1097\/QAD.0000000000002287","article-title":"Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city","volume":"33","author":"Spinelli","year":"2019","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B48","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/cir689","article-title":"Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition","volume":"53","author":"Gallant","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cid\/ciaa1532","article-title":"Innovations in human immunodeficiency virus (HIV) care delivery during the coronavirus disease 2019 (COVID-19) pandemic: policies to strengthen the ending the epidemic initiative","volume":"72","author":"Armstrong","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B50","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1377\/hlthaff.2011.0278","article-title":"Partnering urban academic medical centers and rural primary care clinicians to provide complex chronic disease care","volume":"30","author":"Arora","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"2025030419571680800_ciae479-B51","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.23802","article-title":"Expanding access to hepatitis C virus treatment","volume":"52","author":"Arora","year":"2010","journal-title":"Hepatology"},{"key":"2025030419571680800_ciae479-B52","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"Arora","year":"2011","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B53","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s11606-013-2385-5","article-title":"Mixed-methods evaluation of a telehealth collaborative care program for persons with HIV infection in a rural setting","volume":"28","author":"Ohl","year":"2013","journal-title":"J Gen Intern Med"},{"key":"2025030419571680800_ciae479-B54","doi-asserted-by":"crossref","first-page":"ofw123","DOI":"10.1093\/ofid\/ofw123","article-title":"Impact of a telehealth program that delivers remote consultation and longitudinal mentorship to community HIV providers","volume":"3","author":"Wood","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B55","author":"Medicare Learning Network","year":"2023"},{"key":"2025030419571680800_ciae479-B56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijmedinf.2018.07.007","article-title":"Videoconference compared to telephone in healthcare delivery: a systematic review","volume":"118","author":"Rush","year":"2018","journal-title":"Int J Med Inform"},{"key":"2025030419571680800_ciae479-B57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08964289.2016.1160025","article-title":"Tele-interpersonal psychotherapy acutely reduces depressive symptoms in depressed HIV-infected rural persons: a randomized clinical trial","volume":"43","author":"Heckman","year":"2017","journal-title":"Behav Med"},{"key":"2025030419571680800_ciae479-B58","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/08897077.2016.1176980","article-title":"Factors associated with patterns of mobile technology use among persons who inject drugs","volume":"37","author":"Collins","year":"2016","journal-title":"Subst Abus"},{"key":"2025030419571680800_ciae479-B59","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/10550887.2022.2035166","article-title":"Telehealth for people who inject drugs: an acceptable method of treatment but challenging to access","volume":"40","author":"Delisle-Reda","year":"2022","journal-title":"J Addict Dis"},{"key":"2025030419571680800_ciae479-B60","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.2196\/mhealth.3437","article-title":"Uptake and acceptability of information and communication technology in a community-based cohort of people who inject drugs: implications for mobile health interventions","volume":"3","author":"Genz","year":"2015","journal-title":"JMIR Mhealth Uhealth"},{"key":"2025030419571680800_ciae479-B61","doi-asserted-by":"crossref","first-page":"102905","DOI":"10.1016\/j.drugpo.2020.102905","article-title":"Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19","volume":"93","author":"Davis","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2025030419571680800_ciae479-B62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cid\/ciu222","article-title":"Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls","volume":"59","author":"Young","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B63","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciy907","article-title":"Infectious Diseases Society of America position statement on telehealth and telemedicine as applied to the practice of infectious diseases","volume":"68","author":"Young","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B64","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","article-title":"Harm reduction principles for healthcare settings","volume":"14","author":"Hawk","year":"2017","journal-title":"Harm Reduct J"},{"key":"2025030419571680800_ciae479-B65","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jurban\/jtg053","article-title":"Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users","volume":"80","author":"Altice","year":"2003","journal-title":"J Urban Health"},{"key":"2025030419571680800_ciae479-B66","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/QAD.0000000000002843","article-title":"Evaluation of the POP-UP programme: a multicomponent model of care for people living with HIV with homelessness or unstable housing","volume":"35","author":"Imbert","year":"2021","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B67","doi-asserted-by":"crossref","first-page":"ofz294","DOI":"10.1093\/ofid\/ofz294","article-title":"HIV care for patients with complex needs: a controlled evaluation of a walk-in, incentivized care model","volume":"6","author":"Dombrowski","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 3","key":"2025030419571680800_ciae479-B68","doi-asserted-by":"crossref","first-page":"S353","DOI":"10.1093\/infdis\/jiac267","article-title":"HIV treatment outcomes in POP-UP: drop-in HIV primary care model for people experiencing homelessness","volume":"226","author":"Hickey","year":"2022","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B69","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1370\/afm.2639","article-title":"House calls without walls: street medicine delivers primary care to unsheltered persons experiencing homelessness","volume":"19","author":"Stefanowicz","year":"2021","journal-title":"Ann Fam Med"},{"key":"2025030419571680800_ciae479-B70","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/apc.2017.0313","article-title":"The Max Clinic: medical care designed to engage the hardest-to-reach persons living with HIV in Seattle and King County, Washington","volume":"32","author":"Dombrowski","year":"2018","journal-title":"AIDS Patient Care STDS"},{"key":"2025030419571680800_ciae479-B71","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.2105\/AJPH.2018.304732","article-title":"Mobile multidisciplinary HIV medical care for hard-to-reach individuals experiencing homelessness in San Francisco","volume":"108","author":"Borne","year":"2018","journal-title":"Am J Public Health"},{"key":"2025030419571680800_ciae479-B72","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1525-1497.2004.30418.x","article-title":"Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection","volume":"19","author":"Schneider","year":"2004","journal-title":"J Gen Intern Med"},{"key":"2025030419571680800_ciae479-B73","doi-asserted-by":"crossref","first-page":"e1001863","DOI":"10.1371\/journal.pmed.1001863","article-title":"Retained in HIV care but not on antiretroviral treatment: a qualitative patient-provider dyadic study","volume":"12","author":"Christopoulos","year":"2015","journal-title":"PLoS Med"},{"key":"2025030419571680800_ciae479-B74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciu783","article-title":"Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QAI.0b013e31824bd605","article-title":"Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence","volume":"60","author":"Horberg","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B76","doi-asserted-by":"crossref","first-page":"e0204017","DOI":"10.1371\/journal.pone.0204017","article-title":"Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes","volume":"13","author":"Nash","year":"2018","journal-title":"PLoS One"},{"key":"2025030419571680800_ciae479-B77","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1086\/380969","article-title":"Optimizing the care of minority patients with HIV\/AIDS","volume":"38","author":"Stone","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B78","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/655893","article-title":"Development of national and multiagency HIV care quality measures","volume":"51","author":"Horberg","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/cid\/civ762","article-title":"Quality of HIV care and mortality rates in HIV-infected patients","volume":"62","author":"Korthuis","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B80","volume-title":"A guide to taking a sexual history","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2025030419571680800_ciae479-B81","volume-title":"Duty to warn","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2025030419571680800_ciae479-B82","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2025030419571680800_ciae479-B83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B84","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/cis975","article-title":"Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program","volume":"56","author":"Mind Exchange Working Group","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B85","author":"UCSF Weill Institute for Neurosciences","year":"2017"},{"key":"2025030419571680800_ciae479-B86","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B87","author":"Centers for Disease Control and Prevention Nexus"},{"key":"2025030419571680800_ciae479-B88","author":"Landovitz"},{"key":"2025030419571680800_ciae479-B89","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B90","volume-title":"2018 quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens","author":"Centers for Disease Control and Prevention","year":"2018"},{"key":"2025030419571680800_ciae479-B91","volume-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection","author":"Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV","year":"2023"},{"key":"2025030419571680800_ciae479-B92","first-page":"559","article-title":"2022 update of the drug resistance mutations in HIV-1","volume":"30","author":"Wensing","year":"2022","journal-title":"Top Antivir Med"},{"key":"2025030419571680800_ciae479-B93","author":"Stanford University"},{"key":"2025030419571680800_ciae479-B94","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/ciab583","article-title":"Transmitted drug resistance among human immunodeficiency virus (HIV)-1 diagnoses in the United States, 2014\u20132018","volume":"74","author":"McClung","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B95","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B96","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ndt\/gfv207","article-title":"Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy","volume":"30","author":"Razzak Chaudhary","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2025030419571680800_ciae479-B97","doi-asserted-by":"crossref","first-page":"212519","DOI":"10.7573\/dic.212519","article-title":"Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV","volume":"7","author":"McLaughlin","year":"2018","journal-title":"Drugs Context"},{"key":"2025030419571680800_ciae479-B98","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV","year":"2023"},{"key":"2025030419571680800_ciae479-B99","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B100","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B101","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1016\/j.ijid.2012.03.002","article-title":"Risk factors for tuberculin skin test conversion among HIV-infected patients in New York City","volume":"16","author":"Doshi","year":"2012","journal-title":"Int J Infect Dis"},{"key":"2025030419571680800_ciae479-B102","first-page":"1","article-title":"Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B103","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B104","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"2025030419571680800_ciae479-B105","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B106","author":"American Association for the Study of Liver Diseases, Infectious Diseases Society of America","year":"2023"},{"key":"2025030419571680800_ciae479-B107","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.15585\/mmwr.mm6743a3","article-title":"Hepatitis A virus outbreaks associated with drug use and homelessness\u2014California, Kentucky, Michigan, and Utah, 2017","volume":"67","author":"Foster","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B108","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1258\/095646207782193902","article-title":"Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy","volume":"18","author":"O'Riordan","year":"2007","journal-title":"Int J STD AIDS"},{"key":"2025030419571680800_ciae479-B109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2893.2010.01413.x","article-title":"Hepatitis C virus infection during pregnancy and the newborn period\u2014are they opportunities for treatment?","volume":"18","author":"Arshad","year":"2011","journal-title":"J Viral Hepat"},{"key":"2025030419571680800_ciae479-B110","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV","author":"Panel on Opportunistic Infections in Children With and Exposed to HIV","year":"2023"},{"key":"2025030419571680800_ciae479-B111","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.30823","article-title":"Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"2025030419571680800_ciae479-B112","author":"Centers for Disease Control and Prevention","year":"2020"},{"key":"2025030419571680800_ciae479-B113","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B114","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B115","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/IDR.S148303","article-title":"A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile","volume":"11","author":"Brosio","year":"2018","journal-title":"Infect Drug Resist"},{"key":"2025030419571680800_ciae479-B116","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1545109708315324","article-title":"Prevalence and significance of G6PD deficiency in patients of an urban HIV clinic","volume":"7","author":"Tungsiripat","year":"2008","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"2025030419571680800_ciae479-B117","volume-title":"Glucose-6-phosphate dehydrogenase deficiency","author":"Richardson","year":"2024"},{"key":"2025030419571680800_ciae479-B118","author":"Zash","year":"2022"},{"key":"2025030419571680800_ciae479-B119","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2352-3018(23)00108-X","article-title":"Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008\u201320: a national cohort study","volume":"10","author":"Kourtis","year":"2023","journal-title":"Lancet HIV"},{"key":"2025030419571680800_ciae479-B120","volume-title":"Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States","author":"Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission","year":"2023"},{"key":"2025030419571680800_ciae479-B121","author":"International Society for the Study of the Aging Male"},{"key":"2025030419571680800_ciae479-B122","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1001\/jama.2016.17138","article-title":"Serologic screening for genital herpes: an updated evidence report and systematic review for the US Preventive Services Task Force","volume":"316","author":"Feltner","year":"2016","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B123","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/COH.0b013e32833ed6f4","article-title":"Biomarkers of immune dysfunction in HIV","volume":"5","author":"Nixon","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"2025030419571680800_ciae479-B124","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/sextrans-2019-054208","article-title":"Hepatitis C infection among men who have sex with men living with HIV in New York City, 2000\u20132015","volume":"96","author":"Gabai","year":"2020","journal-title":"Sex Transm Infect"},{"key":"2025030419571680800_ciae479-B126","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amepre.2023.01.005","article-title":"Hepatitis C virus testing and care cascade among transgender and gender diverse individuals","volume":"64","author":"Wolfe","year":"2023","journal-title":"Am J Prev Med"},{"key":"2025030419571680800_ciae479-B127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QCO.0000000000000515","article-title":"Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM","volume":"32","author":"Lockart","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"2025030419571680800_ciae479-B128","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jvh.13286","article-title":"Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England","volume":"27","author":"Bradshaw","year":"2020","journal-title":"J Viral Hepat"},{"key":"2025030419571680800_ciae479-B129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/511038","article-title":"Factors associated with seronegative chronic hepatitis C virus infection in HIV infection","volume":"44","author":"Chamie","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1159\/000521298","article-title":"Hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C","volume":"40","author":"Toka","year":"2022","journal-title":"Dig Dis"},{"key":"2025030419571680800_ciae479-B131","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025030419571680800_ciae479-B132","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/apt.14177","article-title":"No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort","volume":"46","author":"M\u00fccke","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025030419571680800_ciae479-B133","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.2023.9297","article-title":"Screening for depression and suicide risk in adults: US Preventive Services Task Force recommendation statement","volume":"329","author":"US Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B134","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/jama.2018.12086","article-title":"Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"320","author":"O'Connor","year":"2018","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B135","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.2023.9301","article-title":"Screening for anxiety disorders in adults: US Preventive Services Task Force recommendation statement","volume":"329","author":"US Preventive Services Task Force","year":"2023","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B136","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1001\/jama.2020.8020","article-title":"Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement","volume":"323","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B137","doi-asserted-by":"crossref","first-page":"n2183","DOI":"10.1136\/bmj.n2183","article-title":"Accuracy of the Patient Health Questionnaire-9 for screening to detect major depression: updated systematic review and individual participant data meta-analysis","volume":"375","author":"Negeri","year":"2021","journal-title":"BMJ"},{"key":"2025030419571680800_ciae479-B138","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1001\/jama.2020.6504","article-title":"Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis","volume":"323","author":"Levis","year":"2020","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B139","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.15585\/mmwr.mm6547e1","article-title":"Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs\u2014United States","volume":"65","author":"Wejnert","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11904-019-00434-9","article-title":"Substance use screening in HIV care settings: a review and critique of the literature","volume":"16","author":"Hitch","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025030419571680800_ciae479-B141","doi-asserted-by":"crossref","first-page":"21585","DOI":"10.7448\/IAS.20.1.21585","article-title":"Integrating HIV and substance use services: a systematic review","volume":"20","author":"Haldane","year":"2017","journal-title":"J Int AIDS Soc"},{"key":"2025030419571680800_ciae479-B142","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jana.2016.09.003","article-title":"Alcohol screening and brief intervention for persons living with HIV","volume":"28","author":"Sanchez","year":"2017","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2025030419571680800_ciae479-B143","volume-title":"The health consequences of smoking: 50 years of progress. A report of the surgeon general","author":"National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health","year":"2014"},{"key":"2025030419571680800_ciae479-B144","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/infdis\/jiw430","article-title":"Impact of cigarette smoking and smoking cessation on life expectancy among people with HIV: a US-based modeling study","volume":"214","author":"Reddy","year":"2016","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B145","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/tbm\/ibac022","article-title":"Practices, attitudes, and confidence related to tobacco treatment interventions in HIV clinics: a multisite cross-sectional survey","volume":"12","author":"Bold","year":"2022","journal-title":"Transl Behav Med"},{"key":"2025030419571680800_ciae479-B146","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ntr\/ntw126","article-title":"Smoking cessation for people living with HIV\/AIDS: a literature review and synthesis","volume":"18","author":"Ledgerwood","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"2025030419571680800_ciae479-B147","author":"Centers for Disease Control and Prevention","year":"2021"},{"key":"2025030419571680800_ciae479-B148","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jamainternmed.2013.3751","article-title":"Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings","volume":"173","author":"Vidrine","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2025030419571680800_ciae479-B149","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/ntr\/ntz227","article-title":"Quitline treatment enrollment and cessation outcomes among smokers linked with treatment via Ask-Advise-Connect: comparisons among smokers with and without HIV","volume":"22","author":"Bui","year":"2020","journal-title":"Nicotine Tob Res"},{"key":"2025030419571680800_ciae479-B150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/cid\/ciab1069","article-title":"Tobacco use and treatment of tobacco dependence among people with human immunodeficiency virus: a practical guide for clinicians","volume":"75","author":"Reddy","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B151","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2020.23541","article-title":"Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Patnode","year":"2021","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B152","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/medicina58091214","article-title":"Oral manifestations associated with HIV\/AIDS patients","volume":"58","author":"Lomel\u00ed-Mart\u00ednez","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"2025030419571680800_ciae479-B153","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/jama.2022.3267","article-title":"Collaboration and shared decision-making between patients and clinicians in preventive health care decisions and US Preventive Services Task Force recommendations","volume":"327","author":"US Preventive Services Task Force","year":"2022","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B154","first-page":"15","article-title":"Use of standing orders programs to increase adult vaccination rates","volume":"49","author":"McKibben","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B155","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.292.19.2366","article-title":"Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial","volume":"292","author":"Dexter","year":"2004","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B156","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.15585\/mmwr.mm7104a1","article-title":"Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. adults: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7203a1","article-title":"Pneumococcal vaccine for adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023","volume":"72","author":"Kobayashi","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B159","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025030419571680800_ciae479-B160","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.15585\/mmwr.mm7245a5","article-title":"Influenza and up-to-date COVID-19 vaccination coverage among health care personnel\u2014National Healthcare Safety Network, United States, 2022\u201323 influenza season","volume":"72","author":"Bell","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7101a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022\u201323 influenza season","volume":"71","author":"Grohskopf","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B162","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B164","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cid\/ciad201","article-title":"Immunogenicity and safety of hepatitis B virus (HBV) vaccine with a toll-like receptor 9 agonist adjuvant in HBV vaccine-na\u00efve people with human immunodeficiency virus","volume":"77","author":"Marks","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B165","author":"Marks","year":"2024"},{"key":"2025030419571680800_ciae479-B166","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12981-019-0225-3","article-title":"Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody","volume":"16","author":"Laksananun","year":"2019","journal-title":"AIDS Res Ther"},{"key":"2025030419571680800_ciae479-B167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B168","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B169","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/cid\/ciu238","article-title":"Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women","volume":"59","author":"Kojic","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B171","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/cid\/ciy274","article-title":"A randomized, placebo-controlled trial of the quadrivalent human papillomavirus vaccine in human immunodeficiency virus-infected adults aged 27 years or older: AIDS Clinical Trials Group Protocol A5298","volume":"67","author":"Wilkin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B172","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/cid\/ciy575","article-title":"The efficacy of the quadrivalent human papillomavirus vaccine in girls and women living with human immunodeficiency virus","volume":"68","author":"McClymont","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B173","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/cid\/ciy1040","article-title":"Human papillomavirus antibody levels and quadrivalent vaccine clinical effectiveness in perinatally human immunodeficiency virus-infected and exposed, uninfected youth","volume":"69","author":"Moscicki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B174","doi-asserted-by":"crossref","first-page":"100174","DOI":"10.1016\/j.pvr.2019.100174","article-title":"HPV vaccination in HIV infection","volume":"8","author":"Lacey","year":"2019","journal-title":"Papillomavirus Res"},{"key":"2025030419571680800_ciae479-B175","author":"Cavallari","year":"2024"},{"key":"2025030419571680800_ciae479-B176","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12985-018-1039-y","article-title":"Determining the HPV vaccine schedule for a HIV-infected population in sub Saharan Africa, a commentary","volume":"15","author":"Menon","year":"2018","journal-title":"Virol J"},{"key":"2025030419571680800_ciae479-B177","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/M18-3600","article-title":"Recommended adult immunization schedule, United States, 2019","volume":"170","author":"Kim","year":"2019","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B178","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B179","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B180","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3201\/eid2911.230577","article-title":"SARS-CoV-2 reinfection risk in persons with HIV, Chicago, Illinois, USA, 2020\u20132022","volume":"29","author":"Teran","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2025030419571680800_ciae479-B181","doi-asserted-by":"crossref","first-page":"1297195","DOI":"10.3389\/fimmu.2024.1297195","article-title":"Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study","volume":"15","author":"Yendewa","year":"2024","journal-title":"Front Immunol"},{"key":"2025030419571680800_ciae479-B182","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B183","author":"Centers for Disease Control and Prevention. Stay up to date with COVID-19 vaccines","year":"2023"},{"key":"2025030419571680800_ciae479-B184","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm7122e1","article-title":"Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2022","volume":"71","author":"Rao","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B185","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against Mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B186","doi-asserted-by":"crossref","first-page":"ofad528","DOI":"10.1093\/ofid\/ofad528","article-title":"Effectiveness of the modified Vaccinia Ankara vaccine against Mpox in men who have sex with men: a retrospective cohort analysis, Seattle, Washington","volume":"10","author":"Ramchandani","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B187","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1473-3099(23)00492-9","article-title":"Mpox in people with past infection or a complete vaccination course: a global case series","volume":"24","author":"Hazra","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B188","doi-asserted-by":"crossref","first-page":"696","DOI":"10.15585\/mmwr.mm7225a6","article-title":"Notes from the field: emergence of an Mpox cluster primarily affecting persons previously vaccinated against Mpox\u2014Chicago, Illinois, March 18\u2013June 12, 2023","volume":"72","author":"Faherty","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B189","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B190","author":"Advisory Committee on Immunization Practices"},{"key":"2025030419571680800_ciae479-B191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7102a1","article-title":"Cholera vaccine: recommendations of the Advisory Committee on Immunization Practices, 2022","volume":"71","author":"Collins","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B192","first-page":"104563","article-title":"Polio returns to the USA: an epidemiological alert","volume":"82","author":"Rai","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"2025030419571680800_ciae479-B193","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7219a3","article-title":"Progress toward poliomyelitis eradication\u2014worldwide, January 2021\u2013March 2023","volume":"72","author":"Lee","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B194","first-page":"305","article-title":"Updated recommendations for the use of typhoid vaccine","volume":"64","author":"Jackson","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B195","doi-asserted-by":"crossref","first-page":"pkab058","DOI":"10.1093\/jncics\/pkab058","article-title":"Patterns of HIV self-disclosure in the oncology setting","volume":"5","author":"Fuzzell","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"2025030419571680800_ciae479-B196","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1016\/S2352-3018(18)30179-6","article-title":"Incidence of first and second primary cancers diagnosed among people with HIV, 1985\u20132013: a population-based, registry linkage study","volume":"5","author":"Hessol","year":"2018","journal-title":"Lancet HIV"},{"key":"2025030419571680800_ciae479-B197","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/QAD.0b013e3283319184","article-title":"HIV infection and the risk of cancers with and without a known infectious cause","volume":"23","author":"Silverberg","year":"2009","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B198","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cid\/ciw764","article-title":"HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers","volume":"64","author":"Shiels","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B199","doi-asserted-by":"crossref","first-page":"e2224897","DOI":"10.1001\/jamanetworkopen.2022.24897","article-title":"Cancer incidence among adults with HIV in a population-based cohort in Korea","volume":"5","author":"Park","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025030419571680800_ciae479-B200","author":"Coburn","year":"2023"},{"key":"2025030419571680800_ciae479-B201","author":"Dickey","year":"2023"},{"key":"2025030419571680800_ciae479-B202","first-page":"1279","article-title":"Years of life lost to cancer among the United States HIV population, 2006\u20132015","volume":"36","author":"Luo","year":"2022","journal-title":"AIDS"},{"issue":"Suppl 2","key":"2025030419571680800_ciae479-B203","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1097\/QAD.0000000000001449","article-title":"Oncological challenges for an ageing population living with HIV","volume":"31","author":"Dalla Pria","year":"2017","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B204","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thorax.55.12.987","article-title":"Smoking cessation guidelines for health professionals: an update. Health Education Authority","volume":"55","author":"West","year":"2000","journal-title":"Thorax"},{"key":"2025030419571680800_ciae479-B205","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B206","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/QAD.0000000000001818","article-title":"Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells\/\u03bcl","volume":"32","author":"Kong","year":"2018","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B207","author":"American Cancer Society"},{"key":"2025030419571680800_ciae479-B208","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents With HIV"},{"key":"2025030419571680800_ciae479-B209","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"2025030419571680800_ciae479-B210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jama.2019.10987","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US Preventive Services Task Force recommendation statement","volume":"322","author":"Owens","year":"2019","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B211","author":"American Cancer Society"},{"key":"2025030419571680800_ciae479-B212","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1001\/jama.2024.5534","article-title":"Screening for breast cancer: US Preventive Services Task Force recommendation statement","volume":"331","author":"US Preventive Services Task Force","year":"2024","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B213","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal cancer risk among people with HIV infection in the United States","volume":"36","author":"Col\u00f3n-L\u00f3pez","year":"2018","journal-title":"J Clin Oncol"},{"key":"2025030419571680800_ciae479-B214","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International Anal Neoplasia Society's consensus guidelines for anal cancer screening","volume":"154","author":"Stier","year":"2024","journal-title":"Int J Cancer"},{"key":"2025030419571680800_ciae479-B215","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2201048","article-title":"Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer","volume":"386","author":"Palefsky","year":"2022","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B216","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00384-018-3167-7","article-title":"Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience","volume":"34","author":"Tomassi","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"2025030419571680800_ciae479-B217","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/09564624221137974","article-title":"Comparison of anal pre-cancer screening strategies among men who have sex with men","volume":"34","author":"Sun","year":"2023","journal-title":"Int J STD AIDS"},{"key":"2025030419571680800_ciae479-B218","volume-title":"Prostate cancer incidence and mortality by race\/ethnicity, US, 2009\u20132013. Cancer facts and figures 2017","author":"American Cancer Society","year":"2017"},{"key":"2025030419571680800_ciae479-B219","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"key":"2025030419571680800_ciae479-B220","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JU.0000000000003491","article-title":"Early detection of prostate cancer: AUA\/SUO guideline part I: prostate cancer screening","volume":"210","author":"Wei","year":"2023","journal-title":"J Urol"},{"key":"2025030419571680800_ciae479-B221","author":"American College of Obstetrics and Gynecology","year":"2021"},{"key":"2025030419571680800_ciae479-B222","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"2025030419571680800_ciae479-B223","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djab028","article-title":"Cancer stage, treatment, and survival among transgender patients in the United States","volume":"113","author":"Jackson","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"2025030419571680800_ciae479-B224","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"key":"2025030419571680800_ciae479-B225","volume-title":"Sexually transmitted infections surveillance, 2022","author":"Centers for Disease Control and Prevention","year":"2024"},{"key":"2025030419571680800_ciae479-B226","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","article-title":"Mpox in people with advanced HIV infection: a global case series","volume":"401","author":"Mitj\u00e0","year":"2023","journal-title":"Lancet"},{"key":"2025030419571680800_ciae479-B227","doi-asserted-by":"crossref","first-page":"e0264620","DOI":"10.1128\/JCM.02646-20","article-title":"At-home specimen self-collection and self-testing for sexually transmitted infection screening demand accelerated by the COVID-19 pandemic: a review of laboratory implementation issues","volume":"59","author":"Kersh","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"2025030419571680800_ciae479-B228","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.amepre.2021.06.009","article-title":"A pilot of mail-out HIV and sexually transmitted infection testing in Washington, District of Columbia during the COVID-19 pandemic","volume":"61","author":"Fistonich","year":"2021","journal-title":"Am J Prev Med"},{"key":"2025030419571680800_ciae479-B229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7301a1","article-title":"CDC laboratory recommendations for syphilis testing, United States, 2024","volume":"73","author":"Papp","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B230","author":"National Syphilis and Congenital Syphilis Syndemic Federal Task Force"},{"key":"2025030419571680800_ciae479-B231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B232","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC's treatment guidelines for gonococcal infection, 2020","volume":"69","author":"St Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B233","doi-asserted-by":"crossref","first-page":"115854","DOI":"10.1016\/j.diagmicrobio.2022.115854","article-title":"Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China","volume":"105","author":"Li","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025030419571680800_ciae479-B234","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B235","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/vaccines11020246","article-title":"Epidemiologic situation of HIV and monkeypox coinfection: a systematic review","volume":"11","author":"Ortiz-Saavedra","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2025030419571680800_ciae479-B236","doi-asserted-by":"crossref","first-page":"404","DOI":"10.15585\/mmwr.mm7215a5","article-title":"Epidemiologic and clinical features of Mpox-associated deaths\u2014United States, May 10, 2022\u2013March 7, 2023","volume":"72","author":"Riser","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B237","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1473-3099(22)00586-2","article-title":"Viral loads in clinical samples of men with monkeypox virus infection: a French case series","volume":"23","author":"Palich","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B238","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B239","author":"National Institute of Allergy and Infectious Diseases, Division of AIDS"},{"key":"2025030419571680800_ciae479-B240","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B241","volume-title":"Mpox caused by human-to-human transmission of monkeypox virus with geographic spread in the Democratic Republic of the Congo. CDCHAN00501.","author":"Centers for Disease Control and Prevention Health Alert Network","year":"2023"},{"key":"2025030419571680800_ciae479-B242","author":"Centers for Disease Control and Prevention"},{"key":"2025030419571680800_ciae479-B243","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B244","author":"Hyman","year":"2024"},{"key":"2025030419571680800_ciae479-B245","author":"Luetkemeyer","year":"2023"},{"key":"2025030419571680800_ciae479-B246","author":"Molina","year":"2023"},{"key":"2025030419571680800_ciae479-B247","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2\u00d72 factorial design","volume":"24","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B248","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2304007","article-title":"Doxycycline prophylaxis to prevent sexually transmitted infections in women","volume":"389","author":"Stewart","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B249","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad488","article-title":"Potential impact of doxycycline post-exposure prophylaxis prescribing strategies on incidence of bacterial sexually transmitted infections","author":"Traeger","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7302a1","article-title":"CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024","volume":"73","author":"Bachmann","year":"2024","journal-title":"MMWR Recomm Rep"},{"key":"2025030419571680800_ciae479-B251","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cix998","article-title":"Multimorbidity among persons living with human immunodeficiency virus in the United States","volume":"66","author":"Wong","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B252","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12877-018-0789-0","article-title":"The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65\u201374 years and more than 75 years","volume":"18","author":"Guaraldi","year":"2018","journal-title":"BMC Geriatr"},{"key":"2025030419571680800_ciae479-B253","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"The INSIGHT START Study Group","year":"2015","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2025030419571680800_ciae479-B254","first-page":"S1","article-title":"Standards of care in diabetes\u20142023","volume":"46","author":"El Sayed","year":"2022","journal-title":"Diabetes Care"},{"key":"2025030419571680800_ciae479-B255","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2025030419571680800_ciae479-B256","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"2025030419571680800_ciae479-B257","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"2025030419571680800_ciae479-B258","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12603-019-1273-z","article-title":"Physical frailty: ICFSR international clinical practice guidelines for identification and management","volume":"23","author":"Dent","year":"2019","journal-title":"J Nutr Health Aging"},{"key":"2025030419571680800_ciae479-B259","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1468-1293.2007.00470.x","article-title":"Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy","volume":"8","author":"Riddler","year":"2007","journal-title":"HIV Med"},{"key":"2025030419571680800_ciae479-B260","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e32833ad8b4","article-title":"A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206","volume":"24","author":"Tungsiripat","year":"2010","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B261","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/S2352-3018(19)30077-3","article-title":"Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial","volume":"6","author":"Wohl","year":"2019","journal-title":"Lancet HIV"},{"issue":"6 Suppl","key":"2025030419571680800_ciae479-B262","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"key":"2025030419571680800_ciae479-B263","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/QAD.0000000000001167","article-title":"Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection","volume":"30","author":"Longenecker","year":"2016","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B264","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","article-title":"Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"68","author":"Funderburg","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B265","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/cid\/ciu523","article-title":"Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial","volume":"59","author":"Longenecker","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B266","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/infdis\/jiu012","article-title":"Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy","volume":"209","author":"Eckard","year":"2014","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B267","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/cid\/cit748","article-title":"Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy","volume":"58","author":"Funderburg","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B268","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/cid\/civ554","article-title":"Rosuvastatin worsens insulin resistance in HIV-infected adults on antiretroviral therapy","volume":"61","author":"Erlandson","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B269","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B270","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1056\/NEJMc2400870","article-title":"Trial update of pitavastatin to prevent cardiovascular events in HIV infection","volume":"390","author":"Grinspoon","year":"2024","journal-title":"N Engl J Med"},{"key":"2025030419571680800_ciae479-B271","volume-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV: recommendations for the use of statin therapy as primary prevention of atherosclerotic cardiovascular disease in people with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2024"},{"key":"2025030419571680800_ciae479-B272","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s13318-018-0497-3","article-title":"Clinical pharmacokinetics and drug interactions of doravirine","volume":"43","author":"Wilby","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"Suppl 1","key":"2025030419571680800_ciae479-B273","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20132019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabetes Care"},{"key":"2025030419571680800_ciae479-B274","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/apc.2011.0379","article-title":"Glycated hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals","volume":"26","author":"Eckhardt","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"2025030419571680800_ciae479-B275","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc09-0177","article-title":"A1c underestimates glycemia in HIV infection","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care"},{"key":"2025030419571680800_ciae479-B276","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/jac\/dku295","article-title":"Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters","volume":"69","author":"Slama","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2025030419571680800_ciae479-B277","doi-asserted-by":"crossref","first-page":"e0230723","DOI":"10.1371\/journal.pone.0230723","article-title":"Diabetes prevalence by HbA1c and oral glucose tolerance test among HIV-infected and uninfected Tanzanian adults","volume":"15","author":"Jeremiah","year":"2020","journal-title":"PLoS One"},{"key":"2025030419571680800_ciae479-B278","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/M17-0939","article-title":"Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians","volume":"168","author":"Qaseem","year":"2018","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B279","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B280","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B281","doi-asserted-by":"crossref","first-page":"e25702","DOI":"10.1002\/jia2.25702","article-title":"Weight gain before and after switch from TDF to TAF in a U.S. cohort study","volume":"24","author":"Mallon","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"2025030419571680800_ciae479-B282","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/cid\/ciab444","article-title":"Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials","volume":"73","author":"Erlandson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B283","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1016\/S2352-3018(20)30241-1","article-title":"Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial","volume":"7","author":"Venter","year":"2020","journal-title":"Lancet HIV"},{"key":"2025030419571680800_ciae479-B284","doi-asserted-by":"crossref","first-page":"e3902","DOI":"10.1093\/cid\/ciaa1073","article-title":"CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz","volume":"73","author":"Griesel","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B285","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/infdis\/jis720","article-title":"Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202","volume":"207","author":"McComsey","year":"2013","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B286","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/QAD.0000000000002930","article-title":"Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes","volume":"35","author":"McCann","year":"2021","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B287","doi-asserted-by":"crossref","first-page":"101836","DOI":"10.1016\/j.eclinm.2023.101836","article-title":"Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa","volume":"57","author":"Brennan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025030419571680800_ciae479-B288","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/QAI.0000000000002642","article-title":"Brief report: switching to DOR\/3TC\/TDF maintains HIV-1 virologic suppression through week 144 in the DRIVE-SHIFT trial","volume":"87","author":"Kumar","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B289","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/cid\/ciz1243","article-title":"Efficacy and safety of switching to dolutegravir\/lamivudine fixed-dose 2-drug regimen vs continuing a tenofovir alafenamide-based 3- or 4-drug regimen for maintenance of virologic suppression in adults living with human immunodeficiency virus type 1: phase 3, randomized, noninferiority TANGO study","volume":"71","author":"van Wyk","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B290","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae449","volume-title":"Clin Infect Dis","author":"Anderson","year":"2024"},{"key":"2025030419571680800_ciae479-B291","author":"McComsey","year":"2023"},{"key":"2025030419571680800_ciae479-B292","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/cid\/ciac949","article-title":"Weight and metabolic changes after switching from tenofovir alafenamide\/emtricitabine (FTC)+dolutegravir (DTG), tenofovir disoproxil fumarate (TDF)\/FTC + DTG, and TDF\/FTC\/efavirenz to TDF\/lamivudine\/DTG","volume":"76","author":"Bosch","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B293","author":"Tan","year":"2023"},{"key":"2025030419571680800_ciae479-B294","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S2213-8587(24)00150-5","article-title":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","volume":"12","author":"Eckard","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025030419571680800_ciae479-B295","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"2025030419571680800_ciae479-B296","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025030419571680800_ciae479-B297","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","article-title":"Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease","volume":"106","author":"Stanley","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"2025030419571680800_ciae479-B298","article-title":"1984. Effects of semaglutide on adipose tissue in HIV-associated lipohypertrophy","volume":"10","author":"McComsey","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B299","author":"European AIDS Clinical Society","year":"2019"},{"key":"2025030419571680800_ciae479-B300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000002207","article-title":"Management of osteoporosis in patients living with HIV","volume":"83","author":"Starup-Linde","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B301","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/COH.0000000000000269","article-title":"Which HIV patients should be screened for osteoporosis: an international perspective","volume":"11","author":"Alvarez","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"2025030419571680800_ciae479-B302","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00198-018-4794-0","article-title":"Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association Against Osteoporosis","volume":"30","author":"Biver","year":"2019","journal-title":"Osteoporos Int"},{"key":"2025030419571680800_ciae479-B303","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/imj.14357","article-title":"Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic","volume":"49","author":"Davidson","year":"2019","journal-title":"Intern Med J"},{"key":"2025030419571680800_ciae479-B304","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.6537","volume-title":"Screening to prevent osteoporotic fractures: an evidence review for the U.S. Preventive Services Task Force","author":"Viswanathan","year":"2018"},{"key":"2025030419571680800_ciae479-B305","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","article-title":"Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202","volume":"203","author":"McComsey","year":"2011","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B306","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B307","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/infdis\/jiv194","article-title":"Changes in bone mineral density after initiation of antiretroviral treatment with tenofovir disoproxil fumarate\/emtricitabine plus atazanavir\/ritonavir, darunavir\/ritonavir, or raltegravir","volume":"212","author":"Brown","year":"2015","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B308","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/civ327","article-title":"Changes in inflammation and immune activation with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy: ACTG 5260s","volume":"61","author":"Kelesidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B309","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/QAD.0b013e3282ef961d","article-title":"Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV","volume":"21","author":"McComsey","year":"2007","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B310","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/ciz1027","article-title":"Antiretroviral therapy-induced bone loss is durably suppressed by a single dose of zoledronic acid in treatment-naive persons with human immunodeficiency virus infection: a phase IIB trial","volume":"71","author":"Ofotokun","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B311","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2352-3018(19)30195-X","article-title":"Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial","volume":"6","author":"Maggiolo","year":"2019","journal-title":"Lancet HIV"},{"key":"2025030419571680800_ciae479-B312","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAD.0000000000001725","article-title":"Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health","volume":"32","author":"McComsey","year":"2018","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B313","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/M14-2450","article-title":"Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement","volume":"162","author":"LeFevre","year":"2015","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B314","doi-asserted-by":"crossref","first-page":"ofx177","DOI":"10.1093\/ofid\/ofx177","article-title":"Associations between antiretroviral treatment and avascular bone necrosis: the Swiss HIV cohort study","volume":"4","author":"Bayard","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B315","article-title":"Avascular necrosis: a growing concern for the HIV population","volume":"2018","author":"Green","year":"2018","journal-title":"BMJ Case Rep"},{"key":"2025030419571680800_ciae479-B316","first-page":"28","article-title":"Avascular necrosis of the femoral head in HIV positive patients","volume":"25","author":"Chokotho","year":"2013","journal-title":"Malawi Med J"},{"key":"2025030419571680800_ciae479-B317","first-page":"17-0104","article-title":"Hypogonadotropic hypogonadism in human immunodeficiency virus-infected men: uncommonly low testosterone levels","volume":"2017","author":"Gomes","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2025030419571680800_ciae479-B318","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030419571680800_ciae479-B319","author":"Health Canada","year":"2014"},{"key":"2025030419571680800_ciae479-B320","first-page":"759","article-title":"Re: testosterone products: drug safety communication\u2014FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke","volume":"194","author":"Seftel","year":"2015","journal-title":"J Urol"},{"key":"2025030419571680800_ciae479-B321","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4111\/icu.2016.57.6.384","article-title":"Testosterone therapy in men with testosterone deficiency: are we beyond the point of no return?","volume":"57","author":"Traish","year":"2016","journal-title":"Investig Clin Urol"},{"key":"2025030419571680800_ciae479-B322","doi-asserted-by":"crossref","first-page":"e015284","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis","volume":"7","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"key":"2025030419571680800_ciae479-B323","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cen.14633","article-title":"Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism","volume":"96","author":"Jayasena","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025030419571680800_ciae479-B324","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/hiv.12644","article-title":"To T or not to T: differences in testosterone use and discontinuation by HIV serostatus among men who have sex with men","volume":"19","author":"Haberlen","year":"2018","journal-title":"HIV Med"},{"key":"2025030419571680800_ciae479-B325","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/jcm8030410","article-title":"Evolution of guidelines for testosterone replacement therapy","volume":"8","author":"Park","year":"2019","journal-title":"J Clin Med"},{"key":"2025030419571680800_ciae479-B326","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/cid\/ciz670","article-title":"Increased prevalence of neurocognitive impairment in aging people living with human immunodeficiency virus: the ANRS EP58 HAND 55\u201370 study","volume":"70","author":"Makinson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B327","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-associated neurocognitive disorder","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B328","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14283\/jfa.2022.45","article-title":"Frailty and aging in HIV\u2014status post 13 years of national awareness","volume":"12","author":"Eke","year":"2023","journal-title":"J Frailty Aging"},{"key":"2025030419571680800_ciae479-B329","doi-asserted-by":"crossref","first-page":"ofac129","DOI":"10.1093\/ofid\/ofac129","article-title":"Prevalence of frailty and prefrailty in people with human immunodeficiency virus aged 50 or older: a systematic review and meta-analysis","volume":"9","author":"Yamada","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2025030419571680800_ciae479-B330","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/infdis\/jiaa010","article-title":"Frailty is associated with mortality and incident comorbidity among middle-aged human immunodeficiency virus (HIV)-positive and HIV-negative participants","volume":"222","author":"Verheij","year":"2020","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B331","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025030419571680800_ciae479-B332","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Sci World J"},{"key":"2025030419571680800_ciae479-B333","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1097\/QAI.0000000000002074","article-title":"Risk factors for falls, falls with injury, and falls with fracture among older men with or at risk of HIV infection","volume":"81","author":"Erlandson","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B334","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11904-021-00554-1","article-title":"Frailty and HIV: moving from characterization to intervention","volume":"18","author":"Erlandson","year":"2021","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025030419571680800_ciae479-B335","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/AOG.0000000000003013","article-title":"ACOG Committee Opinion No. 762: prepregnancy counseling","volume":"133","author":"American College of Obstetrics and Gynecology","year":"2019","journal-title":"Obstet Gynecol"},{"key":"2025030419571680800_ciae479-B336","first-page":"e89","article-title":"Practice bulletin No. 167: gynecologic care for women and adolescents with human immunodeficiency virus","volume":"128","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2013Gynecology","year":"2016","journal-title":"Obstet Gynecol"},{"key":"2025030419571680800_ciae479-B337","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/cid\/civ578","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B338","author":"National Clinician Consultation Center"},{"key":"2025030419571680800_ciae479-B339","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/cid\/ciad235","article-title":"Breastfeeding among people with human immunodeficiency virus in North America: a multisite study","volume":"77","author":"Levison","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B340","doi-asserted-by":"crossref","first-page":"e2022059604","DOI":"10.1542\/peds.2022-059604","article-title":"Achieving elimination of perinatal HIV in the United States","volume":"151","author":"Lampe","year":"2023","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B341","doi-asserted-by":"crossref","first-page":"e20190657","DOI":"10.1542\/peds.2019-0657","article-title":"Comprehensive health evaluation of the newly adopted child","volume":"143","author":"Jones","year":"2019","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B342","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(15)00087-0","article-title":"Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis","volume":"15","author":"Payne","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2025030419571680800_ciae479-B343","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/QAD.0000000000000178","article-title":"Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children","volume":"28","author":"Ananworanich","year":"2014","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B344","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/QAD.0000000000000677","article-title":"Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed","volume":"29","author":"Kuhn","year":"2015","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2025030419571680800_ciae479-B346","year":"2021"},{"key":"2025030419571680800_ciae479-B347","doi-asserted-by":"crossref","first-page":"18579","DOI":"10.7448\/IAS.16.1.18579","article-title":"Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents","volume":"16","author":"Agwu","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"2025030419571680800_ciae479-B348","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.DBP.0000267570.87564.cd","article-title":"Disclosure of an HIV diagnosis to children: history, current research, and future directions","volume":"28","author":"Wiener","year":"2007","journal-title":"J Dev Behav Pediatr"},{"key":"2025030419571680800_ciae479-B349","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.7448\/IAS.16.1.18466","article-title":"Disclosure of HIV status to children in resource-limited settings: a systematic review","volume":"16","author":"Vreeman","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"2025030419571680800_ciae479-B350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/apc.2016.0067","article-title":"Parenting among adolescents and young adults with human immunodeficiency virus infection in the United States: challenges, unmet needs, and opportunities","volume":"30","author":"Hatfield-Timajchy","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"2025030419571680800_ciae479-B351","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/01.inf.0000242670.11693.56","article-title":"Initiating highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children in Europe and the United States: comparing clinical practice to guidelines and literature evidence","volume":"25","author":"Verweel","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"2025030419571680800_ciae479-B352","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14787210.2021.1829473","article-title":"Adolescents and young adults with early acquired HIV infection in the United States: unique challenges in treatment and secondary prevention","volume":"19","author":"Yusuf","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025030419571680800_ciae479-B353","doi-asserted-by":"crossref","first-page":"e1002514","DOI":"10.1371\/journal.pmed.1002514","article-title":"The epidemiology of adolescents living with perinatally acquired HIV: a cross-region global cohort analysis","volume":"15","author":"Collaborative Initiative for Paediatric HIV Education and Research Global Cohort Collaboration","year":"2018","journal-title":"PLoS Med"},{"key":"2025030419571680800_ciae479-B354","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1542\/peds.2005-0451","article-title":"A behavioral and cognitive profile of clinically stable HIV-infected children","volume":"117","author":"Nozyce","year":"2006","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B355","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0956462415579590","article-title":"Effect of HIV diagnosis disclosure on psychosocial outcomes in Thai children with perinatal HIV infection","volume":"27","author":"Boon-Yasidhi","year":"2016","journal-title":"Int J STD AIDS"},{"key":"2025030419571680800_ciae479-B356","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QAI.0b013e3181f0ccb6","article-title":"Sexual transmission risk behavior of adolescents with HIV acquired perinatally or through risky behaviors","volume":"55","author":"Koenig","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025030419571680800_ciae479-B357","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2105\/AJPH.2005.071910","article-title":"Reproductive health of adolescent girls perinatally infected with HIV","volume":"97","author":"Brogly","year":"2007","journal-title":"Am J Public Health"},{"key":"2025030419571680800_ciae479-B358","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/COH.0000000000000458","article-title":"Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings","volume":"13","author":"Innes","year":"2018","journal-title":"Curr Opin HIV AIDS"},{"key":"2025030419571680800_ciae479-B359","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/QAD.0000000000001731","article-title":"Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents","volume":"32","author":"Geffner","year":"2018","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B360","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCULATIONAHA.113.001978","article-title":"Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation"},{"key":"2025030419571680800_ciae479-B361","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/cid\/ciu672","article-title":"Increased coronary vessel wall thickness in HIV-infected young adults","volume":"59","author":"Abd-Elmoniem","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B362","first-page":"537","article-title":"Preventing and diagnosing HIV-related comorbidities in adolescents","volume":"30","author":"Yusuf","year":"2022","journal-title":"Top Antivir Med"},{"key":"2025030419571680800_ciae479-B363","doi-asserted-by":"crossref","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B364","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2013-1282","article-title":"Office-based care for lesbian, gay, bisexual, transgender, and questioning youth","volume":"132","author":"Committee on Adolescence","year":"2013","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B365","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10461-015-1192-x","article-title":"A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults","volume":"20","author":"Garofalo","year":"2016","journal-title":"AIDS Behav"},{"key":"2025030419571680800_ciae479-B366","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/JNC.0000000000000011","article-title":"Perceptions of HIV self-management roles and challenges in adolescents, caregivers, and health care providers","volume":"30","author":"Mutumba","year":"2019","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2025030419571680800_ciae479-B367","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1186\/s12889-020-09312-1","article-title":"Healthcare retention and clinical outcomes among adolescents living with HIV after transition from pediatric to adult care: a systematic review","volume":"20","author":"Ritchwood","year":"2020","journal-title":"BMC Public Health"},{"key":"2025030419571680800_ciae479-B368","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jadohealth.2018.02.004","article-title":"Healthcare transition for youth living with HIV: outcomes from a prospective multi-site study","volume":"63","author":"Tanner","year":"2018","journal-title":"J Adolesc Health"},{"key":"2025030419571680800_ciae479-B369","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/09540121.2017.1290211","article-title":"Caring for youth living with HIV across the continuum: turning gaps into opportunities","volume":"29","author":"Griffith","year":"2017","journal-title":"AIDS Care"},{"key":"2025030419571680800_ciae479-B370","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09540121.2013.808730","article-title":"Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care","volume":"26","author":"Philbin","year":"2014","journal-title":"AIDS Care"},{"key":"2025030419571680800_ciae479-B371","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/apc.2015.0263","article-title":"The impact of youth-friendly structures of care on retention among HIV-infected youth","volume":"30","author":"Lee","year":"2016","journal-title":"AIDS Patient Care STDS"},{"key":"2025030419571680800_ciae479-B372","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1542\/peds.2013-1073","article-title":"Transitioning HIV-infected youth into adult health care","volume":"132","author":"Committee on Pediatric Aids","year":"2013","journal-title":"Pediatrics"},{"key":"2025030419571680800_ciae479-B373","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2217\/fvl.14.73","article-title":"Transition of youth living with HIV from pediatric to adult-oriented healthcare: a review of the literature","volume":"9","author":"Hussen","year":"2015","journal-title":"Future Virol"},{"key":"2025030419571680800_ciae479-B374","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pedn.2016.04.002","article-title":"Transitioning HIV-positive adolescents to adult care: lessons learned from twelve adolescent medicine clinics","volume":"31","author":"Tanner","year":"2016","journal-title":"J Pediatr Nurs"},{"key":"2025030419571680800_ciae479-B375","volume-title":"CHIVA guidance on transition for adolescents living with HIV","author":"Foster","year":"2023"},{"key":"2025030419571680800_ciae479-B376","volume-title":"How many adults and youth identify as transgender in the United States?","author":"Herman","year":"2022"},{"key":"2025030419571680800_ciae479-B377","volume-title":"The report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"key":"2025030419571680800_ciae479-B378","doi-asserted-by":"crossref","first-page":"e0260063","DOI":"10.1371\/journal.pone.0260063","article-title":"The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis","volume":"16","author":"Stutterheim","year":"2021","journal-title":"PLoS One"},{"key":"2025030419571680800_ciae479-B379","volume-title":"Best practices for asking questions to identify transgender and other gender minority respondents on population-based surveys (GenIUSS)","author":"Badgett","year":"2014"},{"key":"2025030419571680800_ciae479-B380","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12160-013-9565-8","article-title":"Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus","volume":"47","author":"Sevelius","year":"2014","journal-title":"Ann Behav Med"},{"issue":"Suppl 1","key":"2025030419571680800_ciae479-B381","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10461-019-02544-2","article-title":"Evidence for the model of gender affirmation: the role of gender affirmation and healthcare empowerment in viral suppression among transgender women of color living with HIV","volume":"25","author":"Sevelius","year":"2021","journal-title":"AIDS Behav"},{"key":"2025030419571680800_ciae479-B382","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4158\/1934-2403-23.12.1437","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an Endocrine Society clinical practice guideline","volume":"23","author":"Hembree","year":"2017","journal-title":"Endocr Pract"},{"key":"2025030419571680800_ciae479-B383","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2215\/CJN.01890222","article-title":"The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis","volume":"17","author":"Krupka","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025030419571680800_ciae479-B384","doi-asserted-by":"crossref","first-page":"e02492-18","DOI":"10.1128\/AAC.02492-18","article-title":"In vitro evaluation of the drug interaction potential of doravirine","volume":"63","author":"Bleasby","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2025030419571680800_ciae479-B385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5414\/CP201943","article-title":"Lack of an effect of rilpivirine on the pharmacokinetics of ethinylestradiol and norethindrone in healthy volunteers","volume":"52","author":"Crauwels","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2025030419571680800_ciae479-B386","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17425255.2020.1777278","article-title":"Drug interactions with gender-affirming hormone therapy: focus on antiretrovirals and direct acting antivirals","volume":"16","author":"Cirrincione","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2025030419571680800_ciae479-B387","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/lgbt.2017.0057","article-title":"Transgender women living with HIV frequently take antiretroviral therapy and\/or feminizing hormone therapy differently than prescribed due to drug-drug interaction concerns","volume":"4","author":"Braun","year":"2017","journal-title":"LGBT Health"},{"key":"2025030419571680800_ciae479-B388","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1093\/cid\/ciac724","article-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19","volume":"78","author":"Bhimraj","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B389","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1097\/QAD.0000000000002666","article-title":"Characteristics and outcomes of COVID-19 in patients with HIV: a multicentre research network study","volume":"34","author":"Hadi","year":"2020","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B390","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/QAD.0000000000003315","article-title":"Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019\u20132021","volume":"36","author":"Zhu","year":"2022","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B391","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1097\/QAD.0000000000003305","article-title":"Intersecting epidemics: the impact of coronavirus disease 2019 on the HIV prevention and care continua in the United States","volume":"36","author":"Spears","year":"2022","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B392","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B393","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11904-022-00618-w","article-title":"COVID-19 outcomes and risk factors among people living with HIV","volume":"19","author":"Spinelli","year":"2022","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2025030419571680800_ciae479-B394","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.15585\/mmwr.mm7240a3","article-title":"COVID-19\u2013associated hospitalizations among U.S. adults aged \u226565 years\u2014COVID-NET, 13 states, January\u2013August 2023","volume":"72","author":"Taylor","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025030419571680800_ciae479-B395","volume-title":"Underlying medical conditions associated with higher risk for severe COVID-19: information for healthcare professionals","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025030419571680800_ciae479-B396","doi-asserted-by":"crossref","first-page":"e2236397","DOI":"10.1001\/jamanetworkopen.2022.36397","article-title":"Analysis of severe illness after postvaccination COVID-19 breakthrough among adults with and without HIV in the US","volume":"5","author":"Lang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025030419571680800_ciae479-B397","doi-asserted-by":"crossref","first-page":"773","DOI":"10.7326\/M20-3742","article-title":"Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization","volume":"173","author":"Tartof","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025030419571680800_ciae479-B398","doi-asserted-by":"crossref","first-page":"e0276742","DOI":"10.1371\/journal.pone.0276742","article-title":"Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort","volume":"17","author":"Jefferson","year":"2022","journal-title":"PLoS One"},{"key":"2025030419571680800_ciae479-B399","doi-asserted-by":"crossref","first-page":"e2215934","DOI":"10.1001\/jamanetworkopen.2022.15934","article-title":"Analysis of postvaccination breakthrough COVID-19 infections among adults with HIV in the United States","volume":"5","author":"Coburn","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025030419571680800_ciae479-B400","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/jiac229","article-title":"People with human immunodeficiency virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 vaccination and strong third dose responses","volume":"227","author":"Lapointe","year":"2023","journal-title":"J Infect Dis"},{"key":"2025030419571680800_ciae479-B401","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/QAD.0000000000003841","article-title":"Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size","volume":"38","author":"Duncan","year":"2024","journal-title":"AIDS"},{"key":"2025030419571680800_ciae479-B402","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"2025030419571680800_ciae479-B403","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1093\/cid\/ciad084","article-title":"Human immunodeficiency virus status, tenofovir exposure, and the risk of poor coronavirus disease 19 outcomes: real-world analysis from 6 United States cohorts before vaccine rollout","volume":"76","author":"Lea","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025030419571680800_ciae479-B404","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis","volume":"11","author":"Ssentongo","year":"2021","journal-title":"Sci Rep"},{"key":"2025030419571680800_ciae479-B405","volume-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines. Special considerations in people with HIV","author":"COVID-19 Treatment Guidelines Panel","year":"2024"},{"key":"2025030419571680800_ciae479-B406","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1038\/s41467-022-33573-6","article-title":"Post-acute sequelae of SARS-CoV-2 with clinical condition definitions and comparison in a matched cohort","volume":"13","author":"Horberg","year":"2022","journal-title":"Nat Commun"},{"key":"2025030419571680800_ciae479-B407","author":"Yendewa","year":"2023"},{"key":"2025030419571680800_ciae479-B408","author":"Yue","year":"2023"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae479\/61213202\/ciae479.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae479\/61213202\/ciae479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T16:25:05Z","timestamp":1741105505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/advance-article\/doi\/10.1093\/cid\/ciae479\/7818967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":408,"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae479","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"article-number":"ciae479"}}